Company intelligence / Profile preview

QuiO

New York City, New York, United Statesquio.ca ↗

Ownership: Private
Development stage: Preclinical

Overview

QuiO developed a connected drug delivery and adherence monitoring solution for injectable therapies. Their Smartinjector™ devices enabled real-time wireless data transmission to a HIPAA-compliant cloud platform without patient input or smartphone syncing. The company was preparing pilots and regulatory submissions but is no longer active as an independent entity; most recent references are historical or use past tense.

Therapeutic areas: Endocrinology
Modalities: DeviceBiologic
Industry: Therapeutic Medical Devices

Partnerships

SHL Group (strategic partnership on digital connected therapeutics)

Beyond the preview

Go deeper on QuiO.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on QuiO.

Explore the full profile